Back

Efficacy of pitavastatin in patients with HIV: a systematic review and meta-analysis of randomized controlled trials

30 August 2024 (08:00 - 08:50)
Organised by: Logo
Congress Presentation Part of: HIV and cardiovascular disease (1) HIV and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Maria Meritxell Roca Mora

(Luxembourg)

8 More presentations in this session

Presentation thumbnail
Effect of interleukin 1b inhibition with canakinumab on inflammation and viral persistence in people with human immunodeficiency virus
Assistant Professor M. Durstenfeld (Los Angeles, US)
Abstract Slides Video
Presentation thumbnail
Large-scale proteomic profiling reveals characteristic HIV-specific druggable protein signatures associated with incident heart failure
Doctor S. Shakil (Los Angeles, US)
Abstract Slides Video
Presentation thumbnail
Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis.
Professor N. Vuilleumier (Geneva, CH)
Abstract Slides Video
Presentation thumbnail
Influence of disturbed blood flow on endothelial function in people living with HIV
Doctor A. Preveden (Sremska Kamenica, RS)
Abstract Slides Video
Presentation thumbnail
Impaired retinal micro-vascular function in patients with a systemic sclerosis
Ms N. Laptseva (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
HIV and cardiovascular disease (1)

The Event

Event poster

ESC Congress 2024

30 August 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
PCSK9 inhibitors in HIV patients with dyslipidemia
30 August 2024
thumbnail
Congress Presentation
The efficacy of dual lipid-lowering therapy with ezetimibe and statin on plaque volume regression among patients following percutaneous coronary intervention: a meta-analysis
31 August 2025
thumbnail
Congress Presentation
Effect of antiretroviral treatment on myocardial work and arterial function of treatment-naive patients with HIV
31 August 2024
thumbnail
Congress Presentation
Atorvastatin active metabolite inhibits oxidation of Lp(a), small dense LDL and triglyceride-rich lipoproteins compared to other statins through a free radical scavenging mechanism
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources